Catalyst Wire Dossier Catalyst Wire Dossier

PDE5 inhibitor (phosphodiesterase-5 inhibitor)

phosphodiesterase-5 inhibitor
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PDE5 inhibitor (phosphodiesterase-5 inhibitor), covering 2024-02-20 to 2024-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5

See pricing